You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Influenza

Amantadine, oseltamivir and zanamivir for the treatment of influenza

  • Technology appraisal guidance
  • Reference number: TA168
  • Published:  25 February 2009
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Influenza - zanamivir, amantadine and oseltamivir (review): Consultee and commentator comments on the ACD

  • GlaxoSmithKline

  • Roche

  • British Thoracic Society

  • Diabetes UK

  • Royal College of Paediatricians and Child Health

  • Department of Health

  • Welsh Assembly Government


This page was last updated: 30 March 2010

Back to top